Wang, Q., Zhu, X., Li, J., Xu, S., Wang, A., Zhang, X., . . . Yuan, X. HPK1 kinase inhibitor: A sufficient approach to target HPK1 to modulate T cell activation in cancer immunotherapy compared with degraders. Frontiers Media S.A.
Chicago Style (17th ed.) CitationWang, Qin, et al. HPK1 Kinase Inhibitor: A Sufficient Approach to Target HPK1 to Modulate T Cell Activation in Cancer Immunotherapy Compared with Degraders. Frontiers Media S.A.
MLA (9th ed.) CitationWang, Qin, et al. HPK1 Kinase Inhibitor: A Sufficient Approach to Target HPK1 to Modulate T Cell Activation in Cancer Immunotherapy Compared with Degraders. Frontiers Media S.A.
Warning: These citations may not always be 100% accurate.